UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Antiangiogenic therapy in oncology: current status and future directions

The Lancet (British edition), 2016-07, Vol.388 (10043), p.518-529

2016

Link zum Volltext

Verfügbarkeit prüfen

Endothelial Cells Promote the Colorectal Cancer Stem Cell Phenotype through a Soluble Form of Jagged-1

Cancer cell, 2013-02, Vol.23 (2), p.171-185

2013

Link zum Volltext

Verfügbarkeit prüfen

Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis

Journal of clinical oncology, 2005-02, Vol.23 (5), p.1011-1027

2005

Link zum Volltext

Verfügbarkeit prüfen

Pathways Mediating Resistance to Vascular Endothelial Growth Factor–Targeted Therapy

Clinical cancer research, 2008-10, Vol.14 (20), p.6371-6375

2008

Link zum Volltext

Verfügbarkeit prüfen

Resistance to Targeted Therapies: Refining Anticancer Therapy in the Era of Molecular Oncology

Clinical cancer research, 2009-12, Vol.15 (24), p.7471-7478

2009

Link zum Volltext

Verfügbarkeit prüfen

Epithelial-mesenchymal transitioned circulating tumor cells capture for detecting tumor progression

Clinical cancer research, 2015-02, Vol.21 (4), p.899-906

2015

Link zum Volltext

Verfügbarkeit prüfen

The role of neuropilins in cancer

Molecular cancer therapeutics, 2006-05, Vol.5 (5), p.1099-1107

Ellis, Lee M

2006

Link zum Volltext

Verfügbarkeit prüfen

Intracellular ATP Levels Are a Pivotal Determinant of Chemoresistance in Colon Cancer Cells

Cancer research (Chicago, Ill.), 2012-01, Vol.72 (1), p.304-314

2012

Link zum Volltext

Verfügbarkeit prüfen

A survey on data reproducibility in cancer research provides insights into our limited ability to translate findings from the laboratory to the clinic

PloS one, 2013-05, Vol.8 (5), p.e63221-e63221

2013

Link zum Volltext

Verfügbarkeit prüfen

TP53 loss creates therapeutic vulnerability in colorectal cancer

Nature (London), 2015-04, Vol.520 (7549), p.697-701

2015

Link zum Volltext

Verfügbarkeit prüfen

Antiangiogenic therapy--evolving view based on clinical trial results

Nature reviews. Clinical oncology, 2012-05, Vol.9 (5), p.297-303

2012

Link zum Volltext

Verfügbarkeit prüfen

Pragmatic issues in biomarker evaluation for targeted therapies in cancer

Nature reviews. Clinical oncology, 2015-04, Vol.12 (4), p.197-212

2015

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms of Action of Bevacizumab as a Component of Therapy for Metastatic Colorectal Cancer

Seminars in oncology, 2006-10, Vol.33 (5 Suppl 10), p.S1-S7

Ellis, Lee M.

2006

Link zum Volltext

Verfügbarkeit prüfen

Chemoresistant Colorectal Cancer Cells, the Cancer Stem Cell Phenotype, and Increased Sensitivity to Insulin-like Growth Factor-I Receptor Inhibition

Cancer research (Chicago, Ill.), 2009-03, Vol.69 (5), p.1951-1957

2009

Link zum Volltext

Verfügbarkeit prüfen

Combining MEK and SRC inhibitors for treatment of colorectal cancer demonstrate increased efficacy in vitro but not in vivo

PloS one, 2023-03, Vol.18 (3), p.e0281063-e0281063

2023

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance

Journal of clinical oncology, 2010-01, Vol.28 (3), p.453-459

2010

Link zum Volltext

Verfügbarkeit prüfen

Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases

Annals of surgery, 2004-06, Vol.239 (6), p.818-827

2004

Link zum Volltext

Verfügbarkeit prüfen

Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care

The lancet oncology, 2010-04, Vol.11 (4), p.373-382

2010

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of Neoadjuvant Bevacizumab, Capecitabine, and Radiotherapy for Locally Advanced Rectal Cancer

International journal of radiation oncology, biology, physics, 2010-03, Vol.76 (3), p.824-830

2010

Link zum Volltext

Verfügbarkeit prüfen

Finding the tumor copycat: Therapy fails, patients don't

Nature medicine, 2010-09, Vol.16 (9), p.974-975

2010

Link zum Volltext

Verfügbarkeit prüfen

miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase

Molecular oncology, 2014-02, Vol.8 (1), p.83-92

2014

Link zum Volltext

Verfügbarkeit prüfen

Endoglin (CD105): A Marker of Tumor Vasculature and Potential Target for Therapy

Clinical cancer research, 2008-04, Vol.14 (7), p.1931-1937

2008

Link zum Volltext

Verfügbarkeit prüfen

Pathologic Response to Preoperative Chemotherapy: A New Outcome End Point After Resection of Hepatic Colorectal Metastases

Journal of clinical oncology, 2008-11, Vol.26 (33), p.5344-5351

2008

Link zum Volltext

Verfügbarkeit prüfen

Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells

Cancer research (Chicago, Ill.), 2016-05, Vol.76 (10), p.3014-3024

2016

Link zum Volltext

Verfügbarkeit prüfen

Cancer-derived small extracellular vesicles promote angiogenesis by heparin-bound, bevacizumab-insensitive VEGF, independent of vesicle uptake

Communications biology, 2019-10, Vol.2 (1), p.386-386, Article 386

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.503

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.399)
Mit Volltextzugriff
(1.360)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.498)
Japanisch
(212)
Deutsch
(2)
Portugiesisch
(1)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Antiangiogenic therapy in oncology: current status and future directions

Endothelial Cells Promote the Colorectal Cancer Stem Cell Phenotype through a Soluble Form of Jagged-1

Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis

Pathways Mediating Resistance to Vascular Endothelial Growth Factor–Targeted Therapy

Resistance to Targeted Therapies: Refining Anticancer Therapy in the Era of Molecular Oncology

Epithelial-mesenchymal transitioned circulating tumor cells capture for detecting tumor progression

The role of neuropilins in cancer

Intracellular ATP Levels Are a Pivotal Determinant of Chemoresistance in Colon Cancer Cells

A survey on data reproducibility in cancer research provides insights into our limited ability to translate findings from the laboratory to the clinic

TP53 loss creates therapeutic vulnerability in colorectal cancer

Antiangiogenic therapy--evolving view based on clinical trial results

Pragmatic issues in biomarker evaluation for targeted therapies in cancer

Mechanisms of Action of Bevacizumab as a Component of Therapy for Metastatic Colorectal Cancer

Chemoresistant Colorectal Cancer Cells, the Cancer Stem Cell Phenotype, and Increased Sensitivity to Insulin-like Growth Factor-I Receptor Inhibition

Combining MEK and SRC inhibitors for treatment of colorectal cancer demonstrate increased efficacy in vitro but not in vivo

Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance

Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases

Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care

Phase II Trial of Neoadjuvant Bevacizumab, Capecitabine, and Radiotherapy for Locally Advanced Rectal Cancer

Finding the tumor copycat: Therapy fails, patients don't

miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase

Endoglin (CD105): A Marker of Tumor Vasculature and Potential Target for Therapy

Pathologic Response to Preoperative Chemotherapy: A New Outcome End Point After Resection of Hepatic Colorectal Metastases

Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells

Cancer-derived small extracellular vesicles promote angiogenesis by heparin-bound, bevacizumab-insensitive VEGF, independent of vesicle uptake

Suchergebnisse filtern